Pelvic Radiation Disease (PRD) is a long-term side-effect (‘late effect’) of pelvic radiotherapy treatment affecting an estimated 100,000 people in the UK. People affected by PRD often have a complex set of symptoms affecting the bowel, bladder, sexual function or other functions for many years after radiotherapy, sometimes only appearing several years after radiotherapy treatment
PRDA is a small UK charity whose objectives are to see that the effects of PRD are minimised, that people affected by PRD are given the best possible care and treatment, and that PRD is accepted as a serious problem and given the attention it deserves (see Our Vision).
PRDA aims to have an impact by:
- Providing and facilitating direct support and information to people affected by, or at risk of, pelvic radiation disease (PRD);
- Providing a voice for people affected by PRD;
- Inﬂuencing decision-makers to achieve adequate, dedicated funding for PRD services across the UK;
- Working with charity, professional organisations, NHS and other partners to improve health and social services for people affected by PRD;
- Working with charity and professional organisation partners to improve professional awareness and education on the prevention and treatment of PRD;
- Influencing research and trials that address issues to do with PRD.
You can find out more in our latest Annual Report.
Modified: 27th April 2021